Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209014
Status:
TERMINATED
Last Update Posted:
2009-05-07
First Post:
2005-09-13
Brief Title:
Phase II Trial of Thalidomide in RefractoryRelapsed Diffuse Large B-Cell Lymphoma and Hodgkins Disease
Sponsor:
Emory University
Organization:
Emory University